After four years of lab testing and complex neuro-decoding, a research team led by UNLV psychology professor James Hyman has struck a major breakthrough that could open the floodgates for research ...
Cingulate Inc. completes FDA Pre-NDA meeting for ADHD drug CTx-1301 and secures $3 million grant for anxiety treatment CTx-2103. Cingulate Inc. announced the successful completion of a Pre-NDA meeting ...